Glen T. Schumock

6.7k total citations · 1 hit paper
175 papers, 4.9k citations indexed

About

Glen T. Schumock is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Glen T. Schumock has authored 175 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Economics and Econometrics, 38 papers in Geriatrics and Gerontology and 34 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Glen T. Schumock's work include Pharmaceutical Economics and Policy (39 papers), Pharmaceutical Practices and Patient Outcomes (38 papers) and Health Systems, Economic Evaluations, Quality of Life (36 papers). Glen T. Schumock is often cited by papers focused on Pharmaceutical Economics and Policy (39 papers), Pharmaceutical Practices and Patient Outcomes (38 papers) and Health Systems, Economic Evaluations, Quality of Life (36 papers). Glen T. Schumock collaborates with scholars based in United States, Canada and United Kingdom. Glen T. Schumock's co-authors include John P. Thornton, Lee C. Vermeulen, Patrick D. Meek, Todd A. Lee, Robert J. Hunkler, Pamela A. Ploetz, Linda M. Matusiak, A. Simon Pickard, Katie J. Suda and James M. Hoffman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Glen T. Schumock

170 papers receiving 4.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Focusing on the preventability of adverse drug reactions.

1992 490 citations Glen T. Schumock et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Glen T. Schumock United States	36	1.3k	1.2k	924	485	476	175	4.9k
Daniel C. Malone United States	42	2.2k 1.7×	1.2k 1.0×	842 0.9×	886 1.8×	454 1.0×	298	8.0k
Terry S. Field United States	38	2.4k 1.8×	1.1k 0.9×	655 0.7×	1.5k 3.1×	973 2.0×	101	6.4k
R E Ferner United Kingdom	36	844 0.6×	479 0.4×	616 0.7×	233 0.5×	624 1.3×	223	4.9k
Josh F. Peterson United States	42	2.0k 1.5×	726 0.6×	1.1k 1.2×	1.0k 2.1×	1.2k 2.4×	121	9.3k
Ulf Bergman Sweden	43	913 0.7×	1.2k 1.0×	1.0k 1.1×	537 1.1×	89 0.2×	178	6.6k
Michael Dooley Australia	31	1.4k 1.1×	513 0.4×	480 0.5×	468 1.0×	511 1.1×	196	3.6k
Harvey J. Murff United States	34	1.1k 0.8×	494 0.4×	350 0.4×	1.0k 2.1×	1.1k 2.4×	107	6.3k
Patricia M. L. A. van den Bemt Netherlands	40	2.6k 1.9×	502 0.4×	757 0.8×	374 0.8×	1.6k 3.3×	187	4.9k
Alasdair Breckenridge United Kingdom	28	1.1k 0.9×	908 0.8×	1.1k 1.1×	184 0.4×	215 0.5×	89	4.8k
Allen Huang Canada	31	1.9k 1.5×	740 0.6×	342 0.4×	445 0.9×	286 0.6×	77	3.8k

Countries citing papers authored by Glen T. Schumock

Since Specialization

Citations

This map shows the geographic impact of Glen T. Schumock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen T. Schumock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen T. Schumock more than expected).

Fields of papers citing papers by Glen T. Schumock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen T. Schumock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen T. Schumock. The network helps show where Glen T. Schumock may publish in the future.

Co-authorship network of co-authors of Glen T. Schumock

This figure shows the co-authorship network connecting the top 25 collaborators of Glen T. Schumock. A scholar is included among the top collaborators of Glen T. Schumock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen T. Schumock. Glen T. Schumock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Tichy, Eric M., James M. Hoffman, Mina Tadrous, et al.. (2024). National trends in prescription drug expenditures and projections for 2024. American Journal of Health-System Pharmacy. 81(14). 583–598. 12 indexed citations

2.

Sullivan, Patrick S., et al.. (2023). Adherence to HIV Pre-Exposure Prophylaxis Testing Guidelines in the United States. AIDS Patient Care and STDs. 37(7). 337–350. 2 indexed citations

3.

Sullivan, Patrick S., et al.. (2023). Adherence and persistence of HIV pre‐exposure prophylaxis use in the United States. Pharmacoepidemiology and Drug Safety. 33(1). e5729–e5729. 2 indexed citations

4.

Patel, Haridarshan, Gregory S. Calip, Robert J. DiDomenico, et al.. (2020). Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin. JAMA Network Open. 3(9). e2016864–e2016864. 7 indexed citations

5.

Tichy, Eric M., Glen T. Schumock, James M. Hoffman, et al.. (2020). National trends in prescription drug expenditures and projections for 2020. American Journal of Health-System Pharmacy. 77(15). 1213–1230. 38 indexed citations

6.

Devine, Emily Beth, Eleanor M. Perfetto, A. Simon Pickard, et al.. (2018). Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation. Publisher.

7.

Harrington, Rachel, Sruthi Adimadhyam, Todd A. Lee, Glen T. Schumock, & James W. Antoon. (2018). The Relationship Between Oseltamivir and Suicide in Pediatric Patients. The Annals of Family Medicine. 16(2). 145–148. 17 indexed citations

8.

Schumock, Glen T., JoAnn Stubbings, Michelle D. Wiest, et al.. (2018). National trends in prescription drug expenditures and projections for 2018. American Journal of Health-System Pharmacy. 75(14). 1023–1038. 28 indexed citations

9.

Adimadhyam, Sruthi, et al.. (2018). Risk of amputations associated with SGLT2 inhibitors compared to DPP‐4 inhibitors: A propensity‐matched cohort study. Diabetes Obesity and Metabolism. 20(12). 2792–2799. 47 indexed citations

10.

McKoy, June M., et al.. (2018). Anatomy of Risk Evaluation and Mitigation Strategies (REMS). Cancer treatment and research. 171. 93–105. 2 indexed citations

11.

Devine, Emily Beth, Eleanor M. Perfetto, A. Simon Pickard, et al.. (2018). Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation. Journal of Comparative Effectiveness Research. 7(2). 167–175. 1 indexed citations

12.

Hoffman, James M., Edward Li, Fred Doloresco, et al.. (2012). Projecting future drug expenditures—2012. American Journal of Health-System Pharmacy. 69(5). 405–421. 60 indexed citations

13.

Schumock, Glen T., Todd A. Lee, Min J. Joo, et al.. (2011). Association between Leukotriene-Modifying Agents and Suicide. Drug Safety. 34(7). 533–544. 40 indexed citations

14.

Meltzer, David O., et al.. (2010). Exploring the use of social network methods in designing healthcare quality improvement teams. Social Science & Medicine. 71(6). 1119–1130. 89 indexed citations

15.

Lee, Todd A., Caitlyn T. Wilke, Min J. Joo, et al.. (2009). Outcomes Associated With Tiotropium Use in Patients With Chronic Obstructive Pulmonary Disease. Archives of Internal Medicine. 169(15). 1403–1403. 43 indexed citations

16.

Barnum, Darold T., et al.. (2009). Measuring Hospital Efficiency with Data Envelopment Analysis: Nonsubstitutable vs. Substitutable Inputs and Outputs. Journal of Medical Systems. 35(6). 1393–1401. 39 indexed citations

17.

Nutescu, Edith A., et al.. (2005). Factors that influence prescribing within a therapeutic drug class. Journal of Evaluation in Clinical Practice. 11(4). 357–365. 13 indexed citations

18.

Bennett, Charles L., Stefano Luminari, Allen R. Nissenson, et al.. (2004). Pure Red-Cell Aplasia and Epoetin Therapy. New England Journal of Medicine. 351(14). 1403–1408. 284 indexed citations

19.

Nutescu, Edith A., et al.. (2004). Impact of Oral Direct Thrombin Inhibitors on Anticoagulation Clinics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(9). 1204–1212. 4 indexed citations

20.

Klinge, Stephen A., et al.. (2004). Completeness and effectiveness of reporting on three drugs: Lessons learned from RADAR, a novel pharmacosurveillance and pharmacovigilance program. Journal of Clinical Oncology. 22(14_suppl). 3201–3201.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact